If you have been researching mold illness, chronic sinus problems, or CIRS (Chronic Inflammatory Response Syndrome), you have probably run into the term MARCoNS. It looks intimidating, but the idea behind it is straightforward. This guide breaks the term down in plain language and explains why it comes up so often in the mold-recovery world.

What the acronym actually means

MARCoNS stands for Multiple Antibiotic-Resistant Coagulase-Negative Staphylococci. Taken piece by piece:

• Staphylococci (staph) — an extremely common family of bacteria. Many species live harmlessly on skin and in the nose.
• Coagulase-negative — a lab characteristic that separates these species (such as Staphylococcus epidermidis) from Staphylococcus aureus, which is coagulase-positive.
• Multiple antibiotic-resistant — the specific organisms labeled MARCoNS show resistance to two or more classes of antibiotics.

So MARCoNS is not a single species. It is a description of resistant, coagulase-negative staph that can settle into the deep nasal passages and be difficult to clear.

Why MARCoNS comes up in mold-illness conversations

MARCoNS became widely discussed through the work of Dr. Ritchie Shoemaker on biotoxin illness. The idea proposed in that framework is that people with weakened regulation of certain immune signals may be more prone to persistent nasal colonization, and that the colonization can in turn keep inflammatory signaling stirred up. One hormone at the center of that discussion is alpha-MSH (melanocyte-stimulating hormone). You can read more about that in our overview of low MSH and mold-related illness.

It is worth being clear-eyed here: parts of the CIRS model remain debated within mainstream medicine. What is not controversial is that resistant staph can colonize the nasal passages and that biofilms make colonization harder to resolve.

What newer research suggests

A 2026 study published in Frontiers in Endocrinology looked at patients evaluated for CIRS and reported that clearance of MARCoNS colonization was selectively associated with higher alpha-MSH levels. In plain terms, the study found a relationship between clearing the colonization and improved MSH — an association, not proof that any single product causes recovery. It is a useful signal that the nasal microbiome and this hormone system are connected, and a reason the topic deserves more study.

How MARCoNS is tested

MARCoNS is typically assessed with a deep nasal swab sent to a specialized lab, which cultures the sample and runs antibiotic-sensitivity testing. This is different from a shallow swab of the nostril opening, because the organisms of interest tend to live further back. Testing and interpretation belong with a qualified practitioner.

The biofilm piece

One reason MARCoNS can be stubborn is biofilm — a protective matrix bacteria build around themselves that can blunt the reach of antibiotics. That is why so much of the discussion centers on the nasal environment rather than antibiotics alone. We cover the mechanics in how EDTA interacts with biofilms and why oral antibiotics often fall short in chronic sinus infections.

Where to go next

If you are working through this topic, these companion guides go deeper:

• Staph colonization and the nasal passages — the biology in more detail.
• CIRS and the nasal microbiome — how the pieces fit together.
• The nasal microbiome — why this ecosystem matters beyond MARCoNS.

Many people going through this process keep their daily nasal-care routine simple. A xylitol-based option such as our EDTA and xylitol nasal spray is formulated to help rinse, cleanse, and moisturize the nasal passages for comfortable everyday use. It is a hygiene product, not a treatment for any condition — how (or whether) to use nasal products alongside medical care is a conversation to have with your practitioner.

This article is for general educational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Statements about nasal-care products have not been evaluated by the Food and Drug Administration. Talk with a qualified healthcare professional about testing and any treatment decisions.